AstraZeneca Pharma India
Astrazeneca Pharma India Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in AstraZeneca Pharma India
Start SIPAstrazeneca Pharma India Investment Rating
-
Master Rating:
-
Astrazeneca Pharma India has an operating revenue of Rs. 950.23 Cr. on a trailing 12-month basis. An annual revenue de-growth of -1% needs improvement, Pre-tax margin of 10% is healthy, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and close to its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 11% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 96 which is a GREAT score indicating consistency in earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of B is close to being the best. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|
| Oper Rev Qtr Cr | 250 | 236 | 232 | 232 |
| Operating Expenses Qtr Cr | 213 | 195 | 204 | 194 |
| Operating Profit Qtr Cr | 37 | 41 | 28 | 38 |
| Depreciation Qtr Cr | 4 | 3 | 5 | 4 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 10 | 12 | 7 | 9 |
| Net Profit Qtr Cr | 29 | 33 | 20 | 28 |
Astrazeneca Pharma India Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- 3320.89
- 50 Day
- 3333.97
- 100 Day
- 3309.51
- 200 Day
- 3233.65
- 20 Day
- 3325.19
- 50 Day
- 3346.8
- 100 Day
- 3356.35
- 200 Day
- 3203.11
Astrazeneca Pharma India Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 3372.19 |
| Second Resistance | 3397.37 |
| Third Resistance | 3424.94 |
| RSI | 36.57 |
| MFI | 36.85 |
| MACD Single Line | -7.38 |
| MACD | -13.12 |
| Support | |
|---|---|
| First Resistance | 3319.44 |
| Second Resistance | 3291.87 |
| Third Resistance | 3266.69 |
Astrazeneca Pharma India Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 28,200 | 1,446,378 | 51.29 |
| Week | 7,895 | 440,157 | 55.75 |
| 1 Month | 5,715 | 350,221 | 61.28 |
| 6 Month | 10,482 | 511,091 | 48.76 |
Astrazeneca Pharma India Result Highlights
AstraZeneca Pharma India Synopsis
NSE-Medical-Diversified
Astrazeneca Pharma I is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 805.60 Cr. and Equity Capital is Rs. 5.00 Cr. for the Year ended 31/03/2022. AstraZeneca Pharma India Ltd. is a Public Limited Listed company incorporated on 11/07/1979 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L24231KA1979PLC003563 and registration number is 003563.| Market Cap | 7,969 |
| Sales | 950 |
| Shares in Float | 0.63 |
| No of funds | 89 |
| Yield | 0.25 |
| Book Value | 15.58 |
| U/D Vol ratio | 0.6 |
| LTDebt / Equity | |
| Alpha | 0.1 |
| Beta | 0.68 |
AstraZeneca Pharma India
| Owner Name | Dec-22 | Sep-22 | Jun-22 | Mar-22 |
|---|---|---|---|---|
| Promoters | 75% | 75% | 75% | |
| Mutual Funds | 1.22% | 1.09% | 1.07% | |
| Insurance Companies | 0.03% | 0.03% | ||
| Foreign Portfolio Investors | 2.61% | 2.49% | 2.48% | |
| Financial Institutions/ Banks | ||||
| Individual Investors | 18.56% | 18.54% | 18.63% | |
| Others | 2.61% | 2.85% | 2.79% |
AstraZeneca Pharma India Management
| Name | Designation |
|---|---|
| Mr. Narayan K Seshadri | Chairman & Ind.Director |
| Mr. Gagandeep Singh Bedi | Executive Director |
| Mr. Rajesh Marwaha | Executive Director |
| Mr. Ankush Nandra | Non Executive Director |
| Ms. Weiying Sarah Wang | Non Executive Director |
| Ms. Revathy Ashok | Independent Director |
| Ms. Shilpa Shidhar Divekar | Independent Director |
Astrazeneca Pharma India Forecast
Price Estimates
AstraZeneca Pharma India FAQs
What is Share Price of AstraZeneca Pharma India ?
AstraZeneca Pharma India share price is ₹3187 As on 30 March, 2023 | 17:45
What is the Market Cap of AstraZeneca Pharma India ?
The Market Cap of AstraZeneca Pharma India is ₹7968.6 Cr As on 30 March, 2023 | 17:45
What is the P/E ratio of AstraZeneca Pharma India ?
The P/E ratio of AstraZeneca Pharma India is 72.4 As on 30 March, 2023 | 17:45
What is the PB ratio of AstraZeneca Pharma India ?
The PB ratio of AstraZeneca Pharma India is 15.6 As on 30 March, 2023 | 17:45